Guillem Singla Buxarrais

The problem

There are more than 100,000 strokes in the UK each year. Almost two-thirds of stroke survivors leave hospital with a disability and in need of rehabilitation, with arms and hands most commonly affected.

The solution

Through his digital health startup Neurofenix, Guillem Singla Buxarrais is seeking to increase the accessibility and effectiveness of post-stroke rehabilitation with the NeuroBall, a novel and cost-effective medical device making bold changes to stroke rehabilitation.

Physiotherapy exercises can be repetitive and boring, whereas the Neuroball encourages users to exercise the whole arm, from shoulder to fingers, through a set of entertaining games, keeping the user engaged in their therapy.

Engineered with stroke survivors and physiotherapists from inception, the mobile application and handheld controller is a user-friendly device that helps people to regain function in an enjoyable way, as verified in user testing.

Guillem’s experience of volunteering in stroke rehabilitation motivated him to ensure that stroke survivors and physiotherapists were involved with the engineering of the device from inception. The mobile application and handheld controller is user-friendly and helps people to regain function in an enjoyable way, as verified in user testing.

The Neuroball has been engineered to sensitively monitor recovery. It shows stroke survivors their progress, and they can share results with a supportive online community, helping them to feel re-connected with family, friends and other survivors.

Traction

• October 2018: Neuroball available for purchase
• September 2018: £50,000 inaugural Inventor Prize winners
• January 2018: Funding from the Industrial Strategy Challenge Fund

Full URL

---

"The Enterprise Fellowship had a profound impact on Neurofenix’s progress and reducing our time to market. Our mentor and the Enterprise team provided invaluable support throughout."

Guillem Singla Buxarrais

Associated Programme